← Leaderboards
Xin Li
New York University
$11,611,847
Attributed
$16,636,857
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,636,857 · 12
By mechanism
R01$13,515,571 · 6
R42$1,608,347 · 1
R41$921,564 · 3
R21$435,875 · 1
R03$155,500 · 1
Top collaborators
- Deepak Saxena16 shared
- Dana T Graves6 shared
- Deepak Saxena4 shared
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthTissuesOralIn VitroCellsInflammatoryCytokineIn VivoSuccinatesKnockout MiceReceptorSignal TransductionInflammationPathway InteractionsSerumOsteoclastsBacteriaResponseBone ResorptionHomeostasisAffectDiabetic PatientPathogenicityPlay
Grant awards (32)
Targeting Succinate Signaling for Innovative Pain Relief in Oral Cancer.$3,892,146
R01 · FY2025 · DE · contact PI
Succinate signaling in periodontitis induced neuroinflammation and dementia$632,374
R01 · FY2025 · AG · contact PI
Zinc nanocrystals from zinc tetraammine fluoride for caries arrest and remineralization$297,711
R41 · FY2025 · DE
Succinate signaling in periodontitis induced neuroinflammation and dementia$605,318
R01 · FY2024 · AG · contact PI
Succinate triggers gut dysbiosis and activates SUCNR1 to enhance inflammaging$466,319
R01 · FY2024 · AG · contact PI
A Novel Remedy for Periodontal Bone Loss$1,017,222
R42 · FY2023 · DE
Succinate signaling in periodontitis induced neuroinflammation and dementia$610,519
R01 · FY2023 · AG · contact PI
Succinate triggers gut dysbiosis and activates SUCNR1 to enhance inflammaging$476,289
R01 · FY2023 · AG · contact PI
A Novel Remedy for Periodontal Bone Loss$591,125
R42 · FY2022 · DE
Succinate triggers gut dysbiosis and activates SUCNR1 to enhance inflammaging$476,289
R01 · FY2022 · AG · contact PI
Targeting Succinate Signaling Impedes Periodontitis Progression$435,884
R01 · FY2022 · DE
Succinate triggers gut dysbiosis and activates SUCNR1 to enhance inflammaging$495,946
R01 · FY2021 · AG · contact PI
Targeting Succinate Signaling Impedes Periodontitis Progression$434,324
R01 · FY2021 · DE · contact PI
Succinate triggers gut dysbiosis and activates SUCNR1 to enhance inflammaging$514,190
R01 · FY2020 · AG · contact PI
Targeting Succinate Signaling Impedes Periodontitis Progression$444,805
R01 · FY2020 · DE · contact PI
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma$399,752
R41 · FY2020 · CA
Targeting Succinate Signaling Impedes Periodontitis Progression$452,248
R01 · FY2019 · DE · contact PI
Modulation of oral microenvironment by E-cigarette aerosol mixtures$399,537
R01 · FY2019 · DE
A Novel remedy for periodontal bone loss$224,101
R41 · FY2019 · DE
A metabolite accumulated in aged bone directly enhances bone loss$198,125
R21 · FY2019 · AG · contact PI
Targeting Succinate Signaling Impedes Periodontitis Progression$474,261
R01 · FY2018 · DE · contact PI
Modulation of oral microenvironment by E-cigarette aerosol mixtures$399,466
R01 · FY2018 · DE
Targeting Succinate Signaling Impedes Periodontitis Progression$374,821
R01 · FY2018 · DE · contact PI
A metabolite accumulated in aged bone directly enhances bone loss$237,750
R21 · FY2018 · AG · contact PI
Modulation of oral microenvironment by E-cigarette aerosol mixtures$401,876
R01 · FY2017 · DE
Modulation of oral microenvironment by E-cigarette aerosol mixtures$401,739
R01 · FY2016 · DE
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer$307,375
R01 · FY2016 · CA · contact PI
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer$276,937
R01 · FY2015 · CA · contact PI
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer$267,356
R01 · FY2014 · CA · contact PI
Metformin as a novel chemopreventive agent for prostate cancer$76,791
R03 · FY2014 · CA · contact PI
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer$275,552
R01 · FY2013 · CA · contact PI
Metformin as a novel chemopreventive agent for prostate cancer$78,709
R03 · FY2013 · CA · contact PI